Skip to main content
. Author manuscript; available in PMC: 2022 Aug 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2021 Aug 1;87(Suppl 1):S43–S51. doi: 10.1097/QAI.0000000000002704

Table 4.

Sampling fractions and sample sizes for children of mothers with unknown HIV status to achieve target RSE's on pediatric prevalence based on the observed distributions of children and pediatric prevalence by mother's HIV status in phase 1 PHIA surveys

Required sampling fractions and corresponding sample sizes for children of unknown HIV status mothers
Target RSEs on prevalence Lesotho Malawi Namibia Eswatini Tanzania Uganda Zambia Zimbabwe

% N % N % N % N % N % N % N % N

0.05 # # # # # # # # # # # # # # # #
0.10 42% 1,618 41% 2,393 60% 4,206 29% 823 # # # # 22% 1,430 40% 2,598
0.15 12% 474 12% 688 16% 1,145 9% 250 35% 2,686 35% 2,536 7% 442 12% 776
0.20 6% 238 6% 338 8% 560 4% 126 7% 570 15% 1,082 3% 222 6% 388
0.25 4% 145 4% 240 5% 337 3% 77 3% 253 9% 615 2% 135 4% 235
0.30 3% 98 2% 137 3% 227 2% 52 2% 148 6% 401 1% 92 2% 159
0.35 2% 71 2% 99 2% 163 1% 38 1% 99 4% 283 1% 66 2% 115

Number of children of deceased or HIV+ mothers to be tested 2,284 1,909 1,832 1,923 2,077 2,015 2,339 2,592

Note

#

indicates RSEs targets which cannot be achieved given the number of children in sampled households who could be tested in each PHIA country.